Why the study?
Spinal muscular atrophy Type 2 poses considerable anesthetic challenges in pregnancy due to restrictive lung physiology, progressive muscle weakness, and spinal deformity.
Answers are grounded in this paper and cite their sources.
Dexmedetomidine-based TIVA with multimodal analgesia is a feasible and safe anesthetic approach for cesarean delivery in pregnant patients with SMA Type 2.
Background: Spinal muscular atrophy (SMA) Type 2 is a rare autosomal recessive neuromuscular disorder that poses considerable anesthetic challenges in pregnancy, mainly because of restrictive lung physiology, progressive muscle weakness, and spinal deformity. Case Presentation: We report the anesthetic management of a 20-year-old Hispanic primigravida with SMA Type 2 and severe kyphoscoliosis who presented to the hospital at 25 3/7 weeks of gestation with progressive dyspnea. As her respiratory function deteriorated, an urgent cesarean section at 29 5/7 weeks of gestation, together with bilateral salpingectomy, was performed under general anesthesia. Awake nasal fiberoptic intubation was used for airway control, and anesthesia was maintained with an opioid-sparing, dexmedetomidine-based total intravenous anesthesia (TIVA) protocol with minimal adjuncts. Multimodal analgesia was implemented, and postoperative recovery was successful despite delayed extubation. Conclusion: Dexmedetomidine-based TIVA with minimal adjuncts, combined with multimodal analgesia, was a feasible and safe anesthetic approach in this pregnant patient with SMA. Multidisciplinary planning was essential to optimize maternal and fetal outcomes.
No takes yet. Share an insight, caveat, or question.
Sáenz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: